MODIFICATION
R -- Drug Induced Liver Injury Focus Group Planning Services-Biosimulation Methodologies - Revised Performance Work Statement 090824
- Notice Date
- 8/24/2009
- Notice Type
- Modification/Amendment
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 09-223-SOL-00225
- Archive Date
- 8/27/2009
- Point of Contact
- Aaron A. Glazier, Phone: 8705437577
- E-Mail Address
-
aaron.glazier@fda.hhs.gov
(aaron.glazier@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- The document titled "Revised Performance Work Statement 090824" replaces the original PWS that was issued with the solicitation. The only change or addition to the revised PWS can be found in Section VII, Past Performance. Previously, the last sentence in the section was unclear and was missing necessary detail. The missing language has been added to the sentence in the Revised PWS 090824 document.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/09-223-SOL-00225/listing.html)
- Place of Performance
- Address: Silver Springs, Maryland, United States
- Record
- SN01923198-W 20090826/090825000443-2b52e9d2cb151b30c18ee640ecda319c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |